UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035487
Receipt number R000040434
Scientific Title Randomized placebo double-blind study on improvement of blood glucose level by test food for type 2 diabetes preliminary group
Date of disclosure of the study information 2019/02/25
Last modified on 2019/11/30 15:10:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized placebo double-blind study on improvement of blood glucose level by test food for type 2 diabetes preliminary group

Acronym

Diabetes related factor improvement study by test food

Scientific Title

Randomized placebo double-blind study on improvement of blood glucose level by test food for type 2 diabetes preliminary group

Scientific Title:Acronym

Diabetes related factor improvement study by test food

Region

Japan


Condition

Condition

Diabetes preliminary group

Classification by specialty

Medicine in general Endocrinology and Metabolism Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effectiveness by ingesting test food to diabetes related factor

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fasting blood glucose level, HbA1c, QOL score, AGEs measurement at 0,4,8,12 weeks, Sugar tolerance test at 0, 12 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Duration: 12 weeks.
Test materials: Test food
Does: 4.5g per day.

Interventions/Control_2

Duration: 12 weeks.
Test materials: Placebo food
Does: 4.5g per day.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Healthy subjects from 35 years old over.
2. Subjects who can visit the examination place on a fixed schedule.
3. Subjects who can cooperate with weight measurement, a questionnaire and blood sampling test.
4. Subjects who can ingest test food or placebo food dissolved with water etc., once a day during the examination.
5. Subjects who can fill up the examination record everyday.
6.HbA1c is >=5.0%, <6.4%
7.Fasting blood sugar level is 80-110 mg/dl

Key exclusion criteria

1. Subjects who have food allergy. Especially subjects who are sensitive to gelatin.
2. Subjects who have been medical history of physical disorder when they took supplements.
3. Subjects who are diabetes.
4. Subjects who take medicine and/or food for specified health use.
5. Subjects who took supplements and/or medicine for improvement of diabetes 1 month.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Seiko
Middle name
Last name Koizumi

Organization

Nitta Gelatin Inc.

Division name

R&D center

Zip code

581-0024

Address

Futamata 2-22, Yao city, Osaka, Japan

TEL

072-948-8252

Email

se-koizumi@nitta-gelatin.co.jp


Public contact

Name of contact person

1st name Seiko
Middle name
Last name Koizumi

Organization

Nitta Gelatin Inc.

Division name

R&D center

Zip code

581-0024

Address

Futamata 2-22, Yao city, Osaka, Japan

TEL

072-948-8252

Homepage URL


Email

se-koizumi@nitta-gelatin.co.jp


Sponsor or person

Institute

Nitta Gelatin Inc.

Institute

Department

Personal name



Funding Source

Organization

Nitta Gelatin Inc.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nitta Gelatin Ethics Review Committee

Address

Futamata 2-22, Yao city, Osaka, Japan

Tel

072-949-5386

Email

hi-tanaka@nitta-gelatin.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

36

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 09 Month 01 Day

Date of IRB

2018 Year 09 Month 10 Day

Anticipated trial start date

2019 Year 02 Month 22 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 08 Day

Last modified on

2019 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040434


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name